326
N. D. Desai and R. D. Shah
¨
Jansch, H.-J. 4-Aminoisoxazoles by Thorpe cyclization. Liebigs Ann. Chem. 1980,
10, 1623.
4. (a) Curran, D. P.; Liu, W. D. Radical cyclization/fragmentation reactions of dicya-
nocyclopropanes to enaminonitriles. A radical alternative to the Thorpe-Ziegler
reaction. Synlett 1999, 117; (b) Yoshizawa, K.; Toyota, S.; Toda, S. Efficient
solvent-free Thorpe reactions. Green Chem. 2002, 4, 68; (c) Murahashi, S.-I.;
Takaya, H.; Naota, T. Ruthenium catalysis in organic synthesis. Pure Appl.
Chem. 2002, 74, 19.
5. (a) Elguero, J. In Comprehensive Heterocyclic Chemistry; Katritzky, A. Ed.;
Pergamon Press: Oxford, 1984; vol. 5, p. 291; (b) Elguero, J. In Comprehensive
Heterocyclic Chemistry; Katritzky, A., Rees, C. W., Scriven, E. F. V. Eds.;
Elsevier Science Ltd.: Oxford, 1996; vol. 3, pp. 1–75.
6. (a) Penning, T. D.; Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.; Collins, P. W.;
Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.; Miyashiro, J. M.;
Rogers, R. S.; Rogier, D. J.; Yu, S. S.; Anderson, G. D.; Burton, E. G.;
Cogburn, J. N.; Gregory, S. A.; Koboldt, C. M.; Perkins, W. E.; Seibert, K.;
Veenhuizen, A. W.; Zhang, Y. Y.; Isakson, P. C. Synthesis and biological
evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identifi-
cation of 4-[5-(4-methylphenyl)-3- (trifluoromethyl)-1H-pyrazol-1-yl]benzenesul-
fonamide (SC-58635, Celecoxib). J. Med. Chem. 1997, 40, 1347;
(b) Hashimoto, H.; Imamura, K.; Haruta, J.; Wakitani, K. 4-(4-Cycloalkyl/aryl-
oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors:
enhancement of the selectivity by introduction of a fluorine atom and identification
of a potent, highly selective, and orally active COX-2 inhibitor JTE-522. J. Med.
Chem. 2002, 45, 1511; (c) Habeeb, A. G.; Rao, P. N. P.; Knaus, E. E. Design and
synthesis of Celecoxib and Rofecoxib analogues as selective Cyclooxygenase-2
(COX-2) Inhibitors: Replacement of Sulfonamide and Methylsulfonyl Pharmaco-
phores by an Azido Bioisostere. J. Med. Chem. 2001, 44, 3039; (d) Price, M. L. P.;
Jorgensen, W. L. Analysis of Binding Affinities for Celecoxib Analogues with
COX-1 and COX-2 from Combined Docking and Monte Carlo Simulations and
Insight into the COX-2/COX-1 Selectivity. J. Am. Chem. Soc. 2000, 122, 9455.
7. Genin, M. J.; Biles, C.; Keiser, B. J.; Poppe, S. M.; Swaney, S. M.; Tarpley, W. G.;
Yagi, Y.; Romero, D. L. Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse
transcriptase inhibitors with enhanced activity versus the delavirdine-resistant
P236L mutant: lead identification and SAR of 3- and 4-substituted derivatives.
J. Med. Chem. 2000, 43, 1034.
8. Xavier, B.; Beswick, M. C.; Collier, A.; Drysdale, M. J.; Dymock, B. W.; Fink, A.;
Grant, K.; Howes, R.; Jordan, A. M.; Massey, A.; Surgenor, A.; Wayne, J.;
Workman, P.; Wright, L. 4-Amino derivatives of the Hsp90 inhibitor
CCT018159. Bioorg. Med. Chem. Lett. 2006, 16, 2543.
9. (a) Kost, A. N.; Grandberg, I. I. Progress in pyrazole chemistry. Adv. Heterocycl.
Chem. 1966, 6, 347; (b) Heller, S. T.; Natarajan, S. R. 1,3-Diketones from acid
chlorides and ketones: A rapid and general one-pot synthesis of pyrazoles. Org.
Lett. 2006, 8, 2675; (c) Wang, Z.-X.; Qin, H.-L. Solventless syntheses of
pyrazole derivatives. Green Chem. 2004, 6, 90.
10. Moody, C. J. In Comprehensive Organic Synthesis; Trost, B. M., Fleming, I. Eds.;
Pergamon Press: Oxford, 1991; vol. 7, p. 21.
11. Donohue, B. A.; Michelotti, E. L.; Reader, J. C.; Reader, V.; Stirling, M.;
Tice, C. M. Design, synthesis, and biological evaluation of a library of
1-(2-Thiazolyl)-5-(trifluoromethyl)pyrazole-4-carboxamides. J. Comb. Chem.
2002, 4, 23.